RediCare is a digital therapeutics firm, founded in Ireland in 2014 by an experienced multi-disciplined team with backgrounds in Medicine, Nutritional Scientist, Software Engineering and Operations.
Our core product RediCare Control has evolved over 6 years from real world deployment and studies in corporate and primary care settings with clinical input from passionate Cardiologists, Endocrinologists, General Practitioners, Nutritional Scientists, Prescribing Pharmacists, Data Scientists, Software Engineers, and world experts in the field of Artificial Intelligence.
DR NIALL COLWELLConsultant Cardiologist Clinical Advisor
ANDY SHEPPARD MScClinical Lead
LAURA O REILLY MScNutritionist
MICHEAL O CROININOperations Director
CeADAR InstituteArtificial Intelligence
With RediCare ControlDTx patients are transforming their health across the spectrum of metabolic health. They are experiencing clinically significant reductions in Weight, HbA1c, Blood Pressure and Improved Lipid profiles and PCOS remission. Many Type 2 Diabetic patients have reduced and eliminated their diabetes medications.
RediCare ControlDTx is creating a new normal in prescription digital therapeutics for treating cardiometabolic diseases. We envision a new way to treat diseases like Type 2 diabetes and heart disease by targeting the root cause, not just the effects, using prescription digital therapeutics to deliver personalized clinically validated lifestyle therapy.
RediCare partners with primary care practices in the UK and Ireland and serves over 140 corporate clients with chronic disease screening and management services.